Records containing: Polycythemia Vera
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-30A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning
-
CLINICAL_TRIALS study record update · 2025-10-30A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-09-03Prospective Observational Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera
-
CLINICAL_TRIALS study record update · 2025-08-19A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Myeloid Malignancies
-
CLINICAL_TRIALS study record update · 2025-08-13A Phase IIIb, Randomized, Open-Label, Parallel Group, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-njft (P1101) in Adult Patients With Polycythemia Vera (PV)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-07A Phase 2 Study of the Hepcidin Mimetic PTG-300 in Patients With Phlebotomy-Requiring Polycythemia Vera
-
CLINICAL_TRIALS study record update · 2025-08-07A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients With Polycythemia Vera
-
CLINICAL_TRIALS study record update · 2025-08-06An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera (THRIVE)
-
CLINICAL_TRIALS study record update · 2025-08-03A Phase II Single-Arm Multicenter Study to Access Efficacy and Safety of P1101 in Chinese Polycythemia Vera Patients Who Are Intolerant or Resistance to Hydroxyurea
-
CLINICAL_TRIALS study record update · 2025-07-31Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera - A Randomized Open Label Global Multicenter Study (PARADIGM-PV)
-
CLINICAL_TRIALS study record update · 2025-07-29A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bomedemstat in Patients With Polycythemia Vera (PV)
-
CLINICAL_TRIALS study record update · 2025-06-10A Multicenter, Open-Label Phase I Clinical Trial of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)
-
CLINICAL_TRIALS study record update · 2025-05-15Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History
-
CLINICAL_TRIALS study record update · 2025-05-11A Phase Ib, Multicenter, Randomized, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera
-
CLINICAL_TRIALS study record update · 2025-04-02A Phase I Study of ABT-888 in Combination With Topotecan Plus Carboplatin for High-Risk Myeloproliferative Disorders and AML Out of Myeloproliferative Disorders
-
CLINICAL_TRIALS study record update · 2025-01-21Evaluation of Erythrocytosis Prospective Cohort Study (EVEREST): Diagnosis, Management and Longitudinal Outcomes in Patients with Elevated Hemoglobin
-
CLINICAL_TRIALS study record update · 2024-12-16A Single-arm, Single-center Study to Explore the Safety and Efficacy of Pegylated Interferon Alpha in Chinese Patients With ET (Essential Thrombocythemia) and PV (Polycythemia Vera).
-
CLINICAL_TRIALS study record update · 2024-11-18A Phase III, Randomised, Open-label, Multicenter International Trial Comparing Ruxolitinib With Either HydRoxycarbamIDe or Interferon Alpha as First Line ThErapy for High Risk Polycythemia Vera
-
CLINICAL_TRIALS study record update · 2024-09-19The Benefit/Risk Profile of Pegylated Proline-Interferon Alpha-2b (AOP2014) Added to the Best Available Strategy Based on Phlebotomies in Low-risk Patients With Polycythemia Vera (PV). The Low-PV Randomized Trial
-
CLINICAL_TRIALS study record update · 2024-09-19A 2-Part, Phase 2, Open-Label Study of the Safety, Tolerability, and Efficacy of Itacitinib Immediate Release in Participants With Primary Myelofibrosis or Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis or Post-Essential Thrombocythemia Myelofibrosis) Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy
-
CLINICAL_TRIALS study record update · 2024-08-27Clinical and Molecular Epidemiology of Myeloproliferative Neoplasms (MPNs)
-
CLINICAL_TRIALS study record update · 2024-08-12Observatoire Brestois Des Néoplasies Myéloprolifératives
-
CLINICAL_TRIALS study record update · 2024-07-18Clinical and Laboratory Characteristics of Polycythemia Vera
-
CLINICAL_TRIALS study record update · 2024-07-03A Randomized Controlled Study Evaluating the Efficacy and Safety of Pegylated Interferon α-2b in Combination With Ruxolitinib vs. Pegylated Interferon α-2b Monotherapy for Treating Hydroxyurea-resistant/Intolerant Polycythemia Vera
-
CLINICAL_TRIALS study record update · 2024-06-27A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea